StockData
DBV Technologies S.A. logo

DBV Technologies S.A. (DBVT) income statement

DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 6/30
$9.68−0.31 (-3.10%)

Close on Nov 18, 2026Market cap $608.66MP/E –Yield –

See a number that looks wrong?